Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Etude Observationnelle Prospective de l'Utilisation en Situation Reelle; Prospective Real Situation Observational Study of Subutex® or Its Buprenorphine High Dose Generic (BHD) in the Replacement Treatment of Major Opiate Dependence: Following Parameters With Respect to Misuse and Pharmacovigilance

NCT00723697 is registered in ClinicalTrials.gov with Indivior Inc. as lead sponsor.

NCT NCT00723697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00723697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Etude Observationnelle Prospective de l'Utilisation en Situation Reelle; Prospective Real Situation Observational Study of Subutex® or Its Buprenorphine High Dose Generic (BHD) in the Replacement Treatment of Major Opiate Dependence: Following Parameters With Respect to Misuse and Pharmacovigilance
Lead sponsor
Indivior Inc.
Phase
Observational
Overall status
Completed
Start date
May 31, 2007
Completion date
February 28, 2010
Enrollment
1,307 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

buprenorphine, drug abuse, naloxone, opiate dependence, opiate-related disorders